Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study

Abstract

BackgroundPrevious studies have found associations between the use of central nervous system medication and the risk of cognitive decline in the aged. Our aim was to assess whether the use of a single central nervous system (CNS) medication and, on the other hand, the combined use of multiple CNS medications over time are related to the risk of cognitive decline in an older (≥ 65 yrs) population that is cognitively intact at baseline.MethodsWe conducted a longitudinal population-based study of cognitively intact older adults. The participants were 65 years old or older and had Mini-Mental State Examination (MMSE) sum scores of 24 points or higher. The study included a 7.6-year follow-up. The use of benzodiazepines and related drugs (BZDs), antipsychotics (APs), antidepressants (ADs), opioids (Ops), anticholinergics (AChs) and antiepileptics (AEs) was determined at baseline and after a 7.6-years of the follow-up period. Cognitive functioning was used as an outcome variable measured with MMSE at baseline and at the mean follow-up of 7.6 years. Control variables were adjusted with analyses of covariance.ResultsAfter adjusting for control variables, the use of Ops and the concomitant use of Ops and BZDs as well as the use of Ops and any CNS medication were associated with cognitive decline. The use of AChs was associated with decline in cognitive functioning only in men.ConclusionsOf all the CNS medications analyzed in this study, the use of Ops may have the greatest effect on cognitive functioning in the ageing population. Due to small sample sizes these findings cannot be generalized to the unselected ageing population. More studies are needed concerning the long-term use of CNS medications, especially their concomitant use, and their potential cognitive effects.

The Role of Opioid Analgesics in Geriatric Pain Management

“…39 Moreover, a recent meta-analysis showed that opioids also increase the risk of delirium. 40 Meperidine was associated with the greatest risk of delirium, which is not surprising given its renally-cleared neurotoxic metabolite.…”

Cognitive Effects and Sedation

“…In contrast, in a prospective longitudinal study of 37 CNP patients on LTOT, cognitive performance (working memory, spatial span, and processing speed) were deficient when compared to both non‐opioid treated CNP patients and healthy controls . Similarly, a longitudinal analysis of 1,196 cognitively intact older adults with CNP observed cognitive decline on the Mini Mental State Examination (MSE) associated with LTOT or combined opioid and benzodiazepine use over a 7‐year duration, compared to healthy controls . A systematic review of 13 studies demonstrated varied results, with four studies showing improvements or stable cognitive functioning associated with LTOT (e.g., information processing, memory, attention, and psychomotor speed) and 4 studies demonstrating deficits (e.g., working memory, attention, and psychomotor speed) among LTOT patients versus nonopioid treated CNP patients and healthy controls .…”

Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland

“…11,14,15 Observational studies suggest there is considerable interpatient variability in tolerability and opioid-related adverse drug events (ADEs) vary according to the specific agent. 12,16,17 When used among older people, opioids have been associated with abuse, overdose, falls and fractures, 18e21 hospitalizations, 20 cognitive decline, 22,23 and delirium. 24 The use of opioids at the population level has increased substantially over the past decade 25e27 ; however, less is known about the change in opioid prevalence among institutionalized older people.…”